par

Showing 12 posts of 27 posts found.

Medicine top-ups to be allowed

November 5, 2008
Sales and Marketing NICE, par

The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …

PPRS talks stall

October 22, 2008
Sales and Marketing par

Talks on the future of pharmaceutical pricing scheme the PPRS have stumbled into trouble, after it emerged a major part …

Latest news from Datamonitor

September 29, 2008
Sales and Marketing par

Is cost containment impacting pharmaceutical innovation?With the cost of healthcare provision spiraling, governments and payers across the seven major markets …

Ban on ‘top-up’ payments for drugs not working

September 18, 2008
Sales and Marketing NHS, par

The King's Fund says the current ban on NHS patients paying privately for 'top-up' drugs is not working. The Department …

GSK seeks risk-sharing deal for Tyverb

September 17, 2008
Sales and Marketing Cancer, GSK, NICE, par

GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …

Postcode lottery of care persists in England

September 11, 2008
Sales and Marketing par

A new report identifies widespread variations in how much the NHS spends locally on different diseases. The King's Fund says …

Relief as pharma industry secures ‘pro-innovation’ UK pricing deal

July 16, 2008
Sales and Marketing ABPI, par

Agreement has been reached on a new UK medicines pricing deal which safeguards the industry's ability to set its own …

Government remains tight-lipped on PPRS

February 29, 2008
Sales and Marketing par

The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …

Tough talking ahead as government signals end to UK medicines pricing deal

August 2, 2007
ABPI, par

The government has told the UK pharmaceutical industry it wants to talk about the future of medicines pricing in the …

Abbott lowers prices on HIV drugs

April 12, 2007
Sales and Marketing HIV, par

Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …

The Gateway to Local Adoption Series

Latest content